Intech Biopharm Corporation (TPEX: 6461)
Taiwan
· Delayed Price · Currency is TWD 30.65
+1.15 (3.90%)
Sep 11, 2024, 9:38 AM CST
Intech Biopharm Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -351.58 | -337.99 | -327.88 | -301.76 | -250.37 | -311.42 | Upgrade
|
| Depreciation & Amortization | 85.14 | 84.73 | 85.28 | 85.16 | 84.75 | 74.23 | Upgrade
|
| Other Amortization | 0.55 | 0.09 | 0.08 | 0.14 | 0.2 | 0.24 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.58 | -0.28 | -0.93 | -0.3 | - | - | Upgrade
|
| Stock-Based Compensation | 14.1 | 14.13 | 16.89 | 10.64 | 4.3 | 9.37 | Upgrade
|
| Other Operating Activities | 27.06 | 29.92 | 22.59 | 20.05 | 16.23 | 18.74 | Upgrade
|
| Change in Accounts Receivable | 2.3 | 0.56 | 11.38 | -10.28 | -1.5 | 0.25 | Upgrade
|
| Change in Inventory | -8.57 | 9.36 | 6.55 | -4.27 | -12.56 | -28.04 | Upgrade
|
| Change in Accounts Payable | 6.9 | -1.02 | -1.08 | 1.39 | 0.63 | -2.04 | Upgrade
|
| Change in Unearned Revenue | 2.16 | 2.58 | -0.69 | -2.21 | -0.17 | 8.71 | Upgrade
|
| Change in Other Net Operating Assets | -6.66 | -6.21 | -2.59 | 0.84 | -8.87 | 40.87 | Upgrade
|
| Operating Cash Flow | -228.04 | -204.13 | -190.39 | -200.61 | -167.38 | -189.09 | Upgrade
|
| Capital Expenditures | -56.74 | -30.04 | -10.74 | -21.31 | -48.16 | -51.3 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.17 | -0.26 | - | - | - | Upgrade
|
| Investment in Securities | -35 | -210 | -195 | -15 | 5 | -105 | Upgrade
|
| Other Investing Activities | 6.08 | 4.23 | 2.02 | 0.79 | 0.95 | 0.29 | Upgrade
|
| Investing Cash Flow | -85.66 | -235.98 | -203.98 | -35.52 | -42.21 | -156.01 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 30 | - | Upgrade
|
| Long-Term Debt Issued | - | 27 | 270 | - | 250 | 156.48 | Upgrade
|
| Total Debt Issued | -53 | 27 | 270 | - | 280 | 156.48 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -30 | - | -90 | Upgrade
|
| Long-Term Debt Repaid | - | -2 | -15.1 | - | -21.27 | -40.33 | Upgrade
|
| Total Debt Repaid | -2 | -2 | -15.1 | -30 | -21.27 | -130.33 | Upgrade
|
| Net Debt Issued (Repaid) | -55 | 25 | 254.9 | -30 | 258.73 | 26.15 | Upgrade
|
| Issuance of Common Stock | 460 | 460 | 5.06 | 300 | - | 383 | Upgrade
|
| Other Financing Activities | -31.48 | -31.98 | -21.26 | -18.08 | -16.6 | -20.58 | Upgrade
|
| Financing Cash Flow | 373.52 | 453.02 | 238.71 | 251.92 | 242.14 | 388.58 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | 0 | -0 | -0 | 0.01 | 0.29 | Upgrade
|
| Net Cash Flow | 59.85 | 12.91 | -155.66 | 15.8 | 32.57 | 43.77 | Upgrade
|
| Free Cash Flow | -284.78 | -234.17 | -201.13 | -221.91 | -215.54 | -240.39 | Upgrade
|
| Free Cash Flow Margin | -882.27% | -905.98% | -850.56% | -570.48% | -1021.21% | -1440.87% | Upgrade
|
| Free Cash Flow Per Share | -2.18 | -1.94 | -1.73 | -2.18 | -2.15 | -2.95 | Upgrade
|
| Cash Interest Paid | 31.75 | 32.18 | 21.68 | 18.2 | 16.6 | 20.72 | Upgrade
|
| Cash Income Tax Paid | 0.33 | 0.22 | 0.03 | -0 | -0.09 | -0.03 | Upgrade
|
| Levered Free Cash Flow | -192.78 | -150.09 | -108.35 | -137.16 | -137.77 | -161.03 | Upgrade
|
| Unlevered Free Cash Flow | -171.38 | -129.1 | -93.95 | -124.95 | -127.26 | -148.96 | Upgrade
|
| Change in Net Working Capital | 5.07 | -2.46 | -13.61 | 15.83 | 17.99 | -5.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.